drugset / Trial / NCT06125925
Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)
RandomizedParallel-groupSingle-blindTreatment
Summary
To investigate whether RFCA is superior to AADs in AF patients with HFpEF on the basis of optimized anti-heart-failure drug therapy regarding their longterm clinical outcomes.
Timeline
- Start
- 2023-11-06
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amiodarone | Small molecule | — | — |
| Comparator | Dronedarone | Small molecule | — | — |
| Comparator | propafenone | Unknown | — | — |